Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9976455 | 0.91 | F10 (1.00) | F10KLKB1 | |
| SCHEMBL5409814 | 0.91 | F10 (0.84) | F10KLKB1 | |
| SCHEMBL5399426 | 0.91 | F10 (1.00) | F10KLKB1 | |
| SCHEMBL5403144 | 0.89 | F10 (1.00) | F10KLKB1 | |
| Hydrochloric Acid SCHEMBL5441402 | 0.88 | F10 (1.00) | F10KLKB1 | |
| SCHEMBL9979810 | 0.86 | F10 (1.00) | F10KLKB1 | |
| SCHEMBL5406397 | 0.86 | F10 (0.83) | F10KLKB1 | |
| SCHEMBL3061178 | 0.82 | NPC1 (0.78) | — | |
| SCHEMBL2360325 | 0.80 | F10 (0.74) | F10KLKB1 | |
| SCHEMBL9976489 | 0.79 | F10 (1.00) | F10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE43481-E1 | Diazepan derivatives or salts thereof | ASTELLAS PHARMA INC. (JP) | 2012-06-19 | — | — | US | claimed |
| US-RE43481-E1 | Diazepan derivatives or salts thereof | ASTELLAS PHARMA INC. (JP) | 2012-06-19 | — | — | US | disclosed |
| US-RE43481-E1 | Diazepan derivatives or salts thereof | ASTELLAS PHARMA INC. (JP) | 2012-06-19 | — | — | US | disclosed |
| US-7307074-B2 | Activated blood coagulation factor X inhibitor and also to such a pharmaceutical agent and particularly has an excellent activity by oral administration | ASTELLAS PHARMA INC. (JP) | 2007-12-11 | — | — | US | disclosed |
| US-7307074-B2 | Activated blood coagulation factor X inhibitor and also to such a pharmaceutical agent and particularly has an excellent activity by oral administration | ASTELLAS PHARMA INC. (JP) | 2007-12-11 | — | — | US | disclosed |